| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.3 | 0.02 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |